Creo Medical Group PLC (CREO) — Defensive Interval Ratio
Creo Medical Group PLC (CREO) has a Defensive Interval Ratio of 345 days as of December 2025. Defensive assets of GBX6.90 Million (cash GBX-, short-term investments GBX-, receivables GBX6.90 Million) cover 345 days of daily cash needs of GBX20.00K/day. See Creo Medical Group PLC short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Creo Medical Group PLC Defensive Interval Ratio (2005–2025)
This chart shows how Creo Medical Group PLC's Defensive Interval Ratio has evolved across 18 annual periods from 2005 to 2025. As of December 2025, the ratio stands at 345 days, meaning defensive assets of GBX6.90 Million can fund 345 days of operations without new revenue. See Creo Medical Group PLC (CREO) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Creo Medical Group PLC (2005–2025)
The table below presents the year-by-year Defensive Interval Ratio for Creo Medical Group PLC from 2005 to 2025, covering 18 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see CREO market cap overview.
| Year | DIR (days) | Defensive Assets (GBX) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 345 days | GBX6.90 Million | GBX20.00K/day | GBX- | GBX- | ▲ +322 days |
| 2024 | 23 days | GBX1.30 Million | GBX56.16K/day | GBX- | GBX- | ▼ -840 days |
| 2023 | 863 days | GBX23.40 Million | GBX27.12K/day | GBX- | GBX15.50 Million | ▲ +762 days |
| 2022 | 101 days | GBX4.85 Million | GBX47.90K/day | GBX- | GBX-153.00K | ▲ +19 days |
| 2021 | 82 days | GBX4.46 Million | GBX54.07K/day | GBX- | GBX- | ▼ -4 days |
| 2020 | 86 days | GBX4.25 Million | GBX49.39K/day | GBX- | GBX-112.00K | ▼ -208 days |
| 2019 | 294 days | GBX4.08 Million | GBX13.85K/day | GBX- | GBX- | ▼ -444 days |
| 2018 | 738 days | GBX3.32 Million | GBX4.49K/day | GBX- | GBX- | ▲ +290 days |
| 2018 | 448 days | GBX2.31 Million | GBX5.16K/day | GBX- | GBX- | ▲ +29 days |
| 2017 | 419 days | GBX1.69 Million | GBX4.03K/day | GBX- | GBX- | ▲ +295 days |
| 2016 | 124 days | GBX263.61K | GBX2.12K/day | GBX- | GBX- | ▼ -570 days |
| 2016 | 694 days | GBX974.26K | GBX1.40K/day | GBX- | GBX- | ▼ -62 days |
| 2015 | 756 days | GBX613.12K | GBX810.90/day | GBX- | GBX- | ▼ -116 days |
| 2014 | 872 days | GBX598.00K | GBX685.47/day | GBX- | GBX- | ▲ +476 days |
| 2008 | 396 days | GBX63.00K | GBX158.90/day | GBX- | GBX- | ▲ +119 days |
| 2007 | 277 days | GBX186.00K | GBX671.23/day | GBX- | GBX- | ▲ +252 days |
| 2006 | 25 days | GBX5.00K | GBX197.26/day | GBX- | GBX- | ▼ -39 days |
| 2005 | 64 days | GBX3.00K | GBX46.58/day | GBX- | GBX3.00K | — |